Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
9
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Advanced Cancer | 1 |
| Cadonilimab | 1 |
| Capecitabine | 1 |
| Drug Use | 1 |
| First-Line | 1 |
| Nanoliposomal Irinotecan | 1 |
| Oxaliplatin | 1 |
| Pancreatic Adenocarcinoma | 1 |
| Pancreatic cancer | 1 |
Recruiting trials involving Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab
Common questions
How many recruiting trials involve Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab?
1 recruiting trial across 9 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.